Polyomavirus persistence in lymphocytes: prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre Free

Abstract

BK and JC polyomaviruses (BKV and JCV) are widespread in humans and are thought to persist and reactivate under immune alterations. In addition to the kidney, lymphoid cells have been proposed as a site of latency. However, while this was shown to occur in immunocompromised patients, discordant data were published for healthy humans. To help to solve this issue, an extensive study (231 healthy subjects) was carried out on peripheral blood mononuclear cells (PBMC) from blood donors of two towns and from operators of a blood transfusion centre. To discriminate between past and recent infection, nested PCRs for BKV and JCV non-coding control region (NCCR) and VP1 DNA sequences were carried out. Twenty-two per cent of subjects had BKV NCCR, but only 7% also had BKV VP1, as detected by PCR assays of similar sensitivities; the latter positivity was found to decrease with age. In both towns, the BKV WW archetypal DDP strain, subtype I, was found. Only 0·9% of subjects contained JCV DNA, for both NCCR and VP1. Blood operators presented a statistically significant increased prevalence of BKV NCCR (3·0-fold) and BKV VP1 (9·4-fold) sequences with respect to blood donors of comparable ages, suggesting the possibility of occupational risk of BKV (re)infection or reactivation. Since the possibility of amplifying BKV VP1 sequences from PBMC of healthy humans is lost with age, this suggests that PBMC are not a site of polyomavirus persistence in healthy individuals and that detection of BKV VP1 DNA in PBMC is probably indicative of recent infection or reactivation.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-81-8-1967
2000-08-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/81/8/0811967a.html?itemId=/content/journal/jgv/10.1099/0022-1317-81-8-1967&mimeType=html&fmt=ahah

References

  1. Azzi A., De Santis R., Ciappi S., Leoncini F., Sterrantino G., Marino N., Mazzotta F., Laszlo D., Fanci R., Bosi A. 1996; Human polyomavirus DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals. Journal of Neurovirology 2:411–416
    [Google Scholar]
  2. Barbanti-Brodano G., Martini F., De Mattei M., Lazzarin L., Corallini A., Tognon M. 1998; BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors. Advances in Virus Research 50:69–99
    [Google Scholar]
  3. Boldorini R., Caldarelli-Stefano R., Monga G., Zocchi M., Mediati M., Tosoni A., Ferrante P. 1998; PCR detection of JC virus DNA in the brain tissue of a 9-year-old child with pleomorphic xanthoastrocytoma. Journal of Neurovirology 4:242–245
    [Google Scholar]
  4. De Mattei M., Martini F., Tognon M., Serra M., Baldini N., Barbanti-Brodano G. 1994; Polyomavirus latency and human tumors. Journal of Infectious Diseases 169:1175–1176
    [Google Scholar]
  5. De Mattei M., Martini F., Corallini A., Gerosa M., Scotlandi K., Carinci P., Barbanti-Brodano G., Tognon M. 1995; High incidence of BK virus large-T-antigen-coding sequences in normal human tissues and tumors of different histotypes. International Journal of Cancer 61:756–760
    [Google Scholar]
  6. Degener A. M., Pietropaolo V., Di Taranto C., Rizzuti V., Ameglio F., Cordiali Fei P., Caprilli F., Capitanio B., Sinibaldi L., Orsi N. 1997; Detection of JC and BK viral genome in specimens of HIV-1 infected subjects. New Microbiologica 20:115–122
    [Google Scholar]
  7. Degener A. M., Pietropaolo V., Di Taranto C., Jin L., Ameglio F., Cordiali-Fei P., Trento E., Sinibaldi L., Orsi N. 1999; Identification of a new control region in the genome of the DDP strain of BK virus isolated from PBMC. Journal of Medical Virology 58:413–419
    [Google Scholar]
  8. Dorries K. 1998; Molecular biology and pathogenesis of human polyomavirus infections. Developments in Biological Standardization 94:71–79
    [Google Scholar]
  9. Dorries K., Vogel E., Gunther S., Czub S. 1994; Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 198:59–70
    [Google Scholar]
  10. Dubois V., Dutronc H., Lafon M. E., Poinsot V., Pellegrin J. L., Ragnaud J. M., Ferrer A. M., Fleury H. J. 1997; Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients. Journal of Clinical Microbiology 35:2288–2292
    [Google Scholar]
  11. Ferrante P., Omodeo-Zorini E., Caldarelli-Stefano R., Mediati M., Fainardi E., Granieri E., Caputo D. 1998; Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients. Multiple Sclerosis 4:49–54
    [Google Scholar]
  12. Flaegstad T., Sundsfjord A., Arthur R. R., Pedersen M., Traavik T., Subramani S. 1991; Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction. Virology 180:553–560
    [Google Scholar]
  13. Gallia G. L., Houff S. A., Major E. O., Khalili K. 1997; Review: JC virus infection of lymphocytes – revisited. Journal of Infectious Diseases 176:1603–1609
    [Google Scholar]
  14. Gordon J., Krynska B., Otte J., Houff S. A., Khalili K. 1998; Oncogenic potential of human neurotropic papovavirus, JCV, in CNS. Developments in Biological Standardization 94:93–101
    [Google Scholar]
  15. Harris K. F., Chang E., Christensen J. B., Imperiale M. J. 1998; BK virus as a potential co-factor in human cancer. Developments in Biological Standardization 94:81–91
    [Google Scholar]
  16. Jin L., Pietropaolo V., Booth J. C., Ward H. K., Brown D. B. 1995; Prevalence and distribution of BKV in healthy people and immunocompromised patients detected by PCR-restriction enzyme analysis. Clinical and Diagnostic Virology 3:285–295
    [Google Scholar]
  17. Lafon M. E., Dutronc H., Dubois V., Pellegrin I., Barbeau P., Ragnaud J. M., Pellegrin J. L., Fleury H. J. 1998; JC virus remains latent in peripheral blood B lymphocytes but replicates actively in urine from AIDS patients. Journal of Infectious Diseases 177:1502–1505
    [Google Scholar]
  18. Pietropaolo V., Di Taranto C., Degener A. M., Jin L., Sinibaldi L., Baiocchini A., Melis M., Orsi N. 1998; Transplacental transmission of human polyomavirus BK. Journal of Medical Virology 56:372–376
    [Google Scholar]
  19. Rubinstein R., Pare N., Harley E. H. 1987; Structure and function of the transcriptional control region of nonpassaged BK virus. Journal of Virology 61:1747–1750
    [Google Scholar]
  20. Seif I., Khoury G., Dhar R. 1979; The genome of human papovavirus BKV. Cell 18:963–977
    [Google Scholar]
  21. Sundsfjord A., Johansen T., Flaegstad T., Moens U., Villand P., Subramani S., Traavik T. 1990; At least two types of control regions can be found among naturally occurring BK virus strains. Journal of Virology 64:3864–3871
    [Google Scholar]
  22. Sundsfjord A., Flaegstad T., Flø R., Spein A. R., Pedersen M., Permin H., Julsrud J., Traavik T. 1994; BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. Journal of Infectious Diseases 169:485–490
    [Google Scholar]
  23. Tornatore C., Berger J. R., Houff S. A., Curfman B., Meyers K., Winfield D., Major E. O. 1992; Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Annals of Neurology 31:454–462
    [Google Scholar]
  24. Volter C., zur Hausen H., Alber D., de Villiers E. M. 1998; A broad spectrum PCR method for the detection of polyomaviruses and avoidance of contamination by cloning vectors. Developments in Biological Standardization 94:137–142
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-81-8-1967
Loading
/content/journal/jgv/10.1099/0022-1317-81-8-1967
Loading

Data & Media loading...

Most cited Most Cited RSS feed